$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-K Financial Statement

#000072137121000080 Filed on August 16, 2021

Income Statement

Concept	2020 Q2	2019 Q2	2019
Revenue	$36.69B	$37.35B	$145.5B
YoY Change	-1.78%	5.67%	6.38%
Cost Of Revenue	$35.10B	$35.68B	$138.7B
YoY Change	-1.63%	6.14%	7.0%
Gross Profit	$1.590B	$1.674B	$6.834B
YoY Change	-5.02%	-3.52%	-4.83%
Gross Profit Margin	4.33%	4.48%	4.7%
Selling, General & Admin	$1.137B	$1.168B	$4.480B
YoY Change	-2.65%	-8.03%	-2.52%
% of Gross Profit	71.51%	69.77%	65.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$225.0M	$241.0M	$1.000B
YoY Change	-6.64%	-4.74%	-3.1%
% of Gross Profit	14.15%	14.4%	14.63%
Operating Expenses	$1.137B	$1.168B	$4.480B
YoY Change	-2.65%	-8.03%	-2.52%
Operating Profit	$453.0M	$506.0M	$2.060B
YoY Change	-10.47%	8.82%	1534.92%
Interest Expense	$530.0M	-$67.00M	$294.0M
YoY Change	-891.04%	-14.1%	-10.64%
% of Operating Profit	117.0%	-13.24%	14.27%
Other Income/Expense, Net	$22.00M	-$2.000M	-$15.00M
YoY Change	-1200.0%	-93.1%	-34.78%
Pretax Income	$815.0M	$239.0M	$1.478B
YoY Change	241.0%	-120.13%	278.01%
Income Tax	$158.0M	$44.00M	$386.0M
% Of Pretax Income	19.39%	18.41%	26.12%
Net Earnings	$656.0M	$194.0M	$1.363B
YoY Change	238.14%	-116.64%	432.42%
Net Earnings / Revenue	1.79%	0.52%	0.94%
Basic Earnings Per Share			$4.55
Diluted Earnings Per Share	$2.239M	$651.0K	$4.53
COMMON SHARES
Basic Shares Outstanding	292.0M shares	298.1M shares	300.0M shares
Diluted Shares Outstanding			301.0M shares

Balance Sheet

Concept	2020 Q2	2019 Q2	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.771B	$2.531B	$2.531B
YoY Change	9.48%	43.56%	43.56%
Cash & Equivalents	$2.771B	$2.531B	$2.531B
Short-Term Investments
Other Short-Term Assets	$1.707B	$1.946B	$1.946B
YoY Change	-12.28%	1.04%	-27.44%
Inventory	$13.20B	$12.82B	$12.82B
Prepaid Expenses
Receivables	$8.264B	$8.448B	$8.448B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.94B	$25.75B	$25.75B
YoY Change	0.75%	4.86%	4.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.366B	$2.356B	$2.356B
YoY Change	0.42%	-5.27%	-5.27%
Goodwill	$8.357B	$8.378B
YoY Change	-0.25%	0.75%
Intangibles	$2.918B	$3.430B
YoY Change	-14.93%	-12.34%
Long-Term Investments
YoY Change
Other Assets	$1.185B	$1.052B	$1.052B
YoY Change	12.64%	54.25%	54.25%
Total Long-Term Assets	$14.83B	$15.22B	$15.22B
YoY Change	-2.56%	-1.18%	-1.18%
TOTAL ASSETS
Total Short-Term Assets	$25.94B	$25.75B	$25.75B
Total Long-Term Assets	$14.83B	$15.22B	$15.22B
Total Assets	$40.77B	$40.96B	$40.96B
YoY Change	-0.48%	2.53%	2.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.37B	$21.54B	$21.54B
YoY Change	-0.75%	9.44%	9.44%
Accrued Expenses	$2.231B	$2.122B	$2.117B
YoY Change	5.14%	5.99%	5.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.00M	$452.0M	$452.0M
YoY Change	-97.79%	-54.85%	-54.85%
Total Short-Term Liabilities	$23.62B	$24.11B	$24.11B
YoY Change	-2.05%	5.31%	5.31%
LONG-TERM LIABILITIES
Long-Term Debt	$6.765B	$7.579B	$7.579B
YoY Change	-10.74%	-5.4%	-5.4%
Other Long-Term Liabilities	$341.0M
YoY Change
Total Long-Term Liabilities	$7.106B	$7.579B	$7.579B
YoY Change	-6.24%	-5.4%	-5.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.62B	$24.11B	$24.11B
Total Long-Term Liabilities	$7.106B	$7.579B	$7.579B
Total Liabilities	$38.98B	$34.64B	$34.64B
YoY Change	12.54%	2.19%	2.19%
SHAREHOLDERS EQUITY
Retained Earnings	$1.170B	$5.434B
YoY Change	-78.47%	16.99%
Common Stock	$2.789B	$2.763B
YoY Change	0.94%	1.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.066B	$1.790B
YoY Change	15.42%	46.24%
Treasury Stock Shares	34.00M shares	28.00M shares
Shareholders Equity	$1.789B	$6.328B	$6.328B
YoY Change
Total Liabilities & Shareholders Equity	$40.77B	$40.96B	$40.96B
YoY Change	-0.48%	2.53%	2.53%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019
OPERATING ACTIVITIES
Net Income	$656.0M	$194.0M	$1.363B
YoY Change	238.14%	-116.64%	432.42%
Depreciation, Depletion And Amortization	$225.0M	$241.0M	$1.000B
YoY Change	-6.64%	-4.74%	-3.1%
Cash From Operating Activities	$240.0M	$506.0M	$2.722B
YoY Change	-52.57%	-8.0%	-1.66%
INVESTING ACTIVITIES
Capital Expenditures	-$136.0M	-$136.0M	$328.0M
YoY Change	0.0%	-1.45%	-14.58%
Acquisitions			$82.00M
YoY Change			-98.66%
Other Investing Activities	$878.0M	-$37.00M	$666.0M
YoY Change	-2472.97%	1750.0%	-112.75%
Cash From Investing Activities	$742.0M	-$173.0M	$338.0M
YoY Change	-528.9%	23.57%	-106.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$600.0M
YoY Change			9.09%
Debt Paid & Issued, Net			$1.102B
YoY Change			15.51%
Cash From Financing Activities	-528.0M	-1.243B	-$2.293B
YoY Change	-57.52%	53.65%	0.75%
NET CHANGE
Cash From Operating Activities	240.0M	506.0M	$2.722B
Cash From Investing Activities	742.0M	-173.0M	$338.0M
Cash From Financing Activities	-528.0M	-1.243B	-$2.293B
Net Change In Cash	454.0M	-910.0M	$768.0M
YoY Change	-149.89%	128.07%	-115.01%
FREE CASH FLOW
Cash From Operating Activities	$240.0M	$506.0M	$2.722B
Capital Expenditures	-$136.0M	-$136.0M	$328.0M
Free Cash Flow	$376.0M	$642.0M	$2.394B
YoY Change	-41.43%	-6.69%	0.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000721371
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-11373
CY2021	dei	Entity Registrant Name EntityRegistrantName	Cardinal Health, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-0958666
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 Cardinal Place
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43017
CY2021	dei	City Area Code CityAreaCode	(614)
CY2021	dei	Local Phone Number LocalPhoneNumber	757-5000
CY2021	dei	Security12b Title Security12bTitle	Common shares (without par value)
CY2021	dei	Trading Symbol TradingSymbol	CAH
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Public Float EntityPublicFloat	15693865917	USD
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	290441408	shares
CY2021	us-gaap	Revenues Revenues	162467000000	USD
CY2020	us-gaap	Revenues Revenues	152922000000	USD
CY2019	us-gaap	Revenues Revenues	145534000000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	155689000000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146054000000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	138700000000	USD
CY2021	us-gaap	Gross Profit GrossProfit	6778000000	USD
CY2020	us-gaap	Gross Profit GrossProfit	6868000000	USD
CY2019	us-gaap	Gross Profit GrossProfit	6834000000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4533000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4572000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4480000000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	114000000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	122000000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	125000000	USD
CY2021	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	451000000	USD
CY2020	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	524000000	USD
CY2019	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	621000000	USD
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-79000000	USD
CY2020	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-7000000	USD
CY2019	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	488000000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1129000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-5741000000	USD
CY2019	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-36000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	472000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4098000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	2060000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	180000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	238000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	294000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2000000	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	579000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	323000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3772000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1751000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-289000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-79000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	386000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	612000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3693000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1365000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	611000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3696000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1363000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.09
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.61
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.55
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.61
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	292000000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	293000000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	300000000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	294000000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	293000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	301000000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	612000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3693000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1365000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	46000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	24000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-28000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-5000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	70000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	682000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3718000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1378000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	681000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3721000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1376000000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3407000000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2771000000	USD
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	9103000000	USD
CY2020Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8264000000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	14594000000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	13198000000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2843000000	USD
CY2020Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1707000000	USD
CY2021Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	1101000000	USD
CY2020Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	31048000000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	25940000000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2360000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366000000	USD
CY2021Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	10094000000	USD
CY2020Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	11275000000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	951000000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1185000000	USD
CY2021Q2	us-gaap	Assets Assets	44453000000	USD
CY2020Q2	us-gaap	Assets Assets	40766000000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	23700000000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	21374000000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	871000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	10000000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2957000000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2231000000	USD
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	96000000	USD
CY2020Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	27624000000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23615000000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5365000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6765000000	USD
CY2021Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	9670000000	USD
CY2020Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	8594000000	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	2806000000	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	2789000000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1205000000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1170000000	USD
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	36000000	shares
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	34000000	shares
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2186000000	USD
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2066000000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-34000000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-104000000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1791000000	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	3000000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1789000000	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	3000000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1794000000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1792000000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44453000000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40766000000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6059000000	USD
CY2019	cah	Net Earnings Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	1365000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	67000000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	600000000	USD
CY2019	us-gaap	Dividends Dividends	575000000	USD
CY2019	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6330000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3696000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3693000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-25000000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	350000000	USD
CY2020	us-gaap	Dividends Dividends	570000000	USD
CY2020	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1792000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	611000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	612000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	70000000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97000000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	200000000	USD
CY2021	us-gaap	Dividends Dividends	576000000	USD
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1794000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	612000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3693000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1365000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	783000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	913000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000000000	USD
CY2021	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	-3000000	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2000000	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	579000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-79000000	USD
CY2020	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-7000000	USD
CY2019	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	488000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	89000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	90000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	82000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	496000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-961000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83000000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	65000000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	106000000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000000	USD
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	904000000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-82000000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	751000000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1584000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	409000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	551000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2325000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-162000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1864000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-452000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6550000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-193000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2429000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1960000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2722000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3000000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	82000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	400000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	375000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328000000	USD
CY2021	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	22000000	USD
CY2020	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	20000000	USD
CY2019	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	18000000	USD
CY2021	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	47000000	USD
CY2020	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	886000000	USD
CY2019	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	3000000	USD
CY2021	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	0	USD
CY2020	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	2000000	USD
CY2019	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	763000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-378000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	493000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	338000000	USD
CY2021	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-2000000	USD
CY2019	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2021	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-18000000	USD
CY2020	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-112000000	USD
CY2021Q2	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.50
CY2019	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	0	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	570000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1399000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1102000000	USD
CY2021	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	8000000	USD
CY2020	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	8000000	USD
CY2019	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-14000000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	573000000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	569000000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	577000000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	350000000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	600000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1317000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2200000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2293000000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	11000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-13000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1000000	USD
CY2021	cah	Cash Reclassifiedto Assets Heldfor Sale CashReclassifiedtoAssetsHeldforSale	-109000000	USD
CY2020	cah	Cash Reclassifiedto Assets Heldfor Sale CashReclassifiedtoAssetsHeldforSale	0	USD
CY2019	cah	Cash Reclassifiedto Assets Heldfor Sale CashReclassifiedtoAssetsHeldforSale	0	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	636000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	240000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	768000000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2771000000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2531000000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1763000000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3407000000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2771000000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2531000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	182000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	226000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	285000000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	273000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	368000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	311000000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation and reserves, goodwill and other intangible asset impairment, loss contingencies (including product liability and self-insurance accruals), and income taxes. Actual amounts could ultimately differ from these estimated amounts.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19") continues to affect the U.S. and global economies, and as previously disclosed, the pandemic began to materially affect our businesses during the third quarter of fiscal 2020. The length and severity of the pandemic and its impacts on our businesses and results of operations are uncertain.</span></div>
CY2021Q2	us-gaap	Notes Receivable Net NotesReceivableNet	63000000	USD
CY2021Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7000000	USD
CY2020Q2	us-gaap	Notes Receivable Net NotesReceivableNet	104000000	USD
CY2020Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	12000000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses.</span></div>Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with certain large customers and with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. With respect to customers in the retail and healthcare sectors, such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers’ financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts.
CY2021	cah	Concentration Risk Largest Group Purchasing Organizations ConcentrationRiskLargestGroupPurchasingOrganizations	2	organization
CY2021	cah	Concentration Risk Largest Group Purchasing Organizations ConcentrationRiskLargestGroupPurchasingOrganizations	2	organization
CY2020Q2	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.56
CY2021Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	565000000	USD
CY2020Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	411000000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	197000000	USD
CY2021Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	185000000	USD
CY2020Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	155000000	USD
CY2021	us-gaap	Depreciation Depreciation	377000000	USD
CY2020	us-gaap	Depreciation Depreciation	405000000	USD
CY2019	us-gaap	Depreciation Depreciation	455000000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5588000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5331000000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3228000000	USD
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2965000000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2360000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366000000	USD
CY2021Q2	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.03
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	cah	Vendor Reserves VendorReserves	77000000	USD
CY2020Q2	cah	Vendor Reserves VendorReserves	77000000	USD
CY2021	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain other parties under acquisition and disposition agreements, customer agreements, intellectual property licensing agreements, and other agreements. Such indemnification obligations vary in scope and, when defined, in duration. In many cases, a maximum obligation is not explicitly stated, and therefore the overall maximum amount of the liability under such indemnification obligations cannot be reasonably estimated. Where appropriate, such indemnification obligations are recorded as a liability. Historically, we have not, individually or in the aggregate, made </span></div>payments under these indemnification obligations in any material amounts. In certain circumstances, we believe that existing insurance arrangements, subject to the general deduction and exclusion provisions, would cover portions of the liability that may arise from these indemnification obligations. In addition, we believe that the likelihood of a material liability being triggered under these indemnification obligations is not probable.From time to time we enter into agreements that obligate us to make fixed payments upon the occurrence of certain events. Such obligations primarily relate to obligations arising under acquisition transactions, where we have agreed to make payments based upon the achievement of certain financial performance measures by the acquired business. Generally, the obligation is capped at an explicit amount. There were no material obligations at June 30, 2021.
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.94
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.92
CY2019	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.91
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2000000	USD
CY2021Q2	cah	Revenue Recognition Reservefor Sales Returnsand Allowances RevenueRecognitionReserveforSalesReturnsandAllowances	689000000	USD
CY2020Q2	cah	Revenue Recognition Reservefor Sales Returnsand Allowances RevenueRecognitionReserveforSalesReturnsandAllowances	495000000	USD
CY2021	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	2600000000	USD
CY2020	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	2300000000	USD
CY2019	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	2200000000	USD
CY2021	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate, Currency and Commodity Risk</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders’ equity through AOCI, net of tax.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract’s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. Interest payments </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">received from the cross currency swap are excluded from the net investment hedge effectiveness assessment and are recorded in interest expense, net in the consolidated statements of earnings/(loss).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4f0ec56b9c604f1782a65ea4a19c284d_139" style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 10</a></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow, net investment and economic hedges.</span></div>
CY2019Q2	us-gaap	Restructuring Reserve RestructuringReserve	72000000	USD
CY2020	us-gaap	Restructuring Costs RestructuringCosts	109000000	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	85000000	USD
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	96000000	USD
CY2021	us-gaap	Restructuring Costs RestructuringCosts	75000000	USD
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	92000000	USD
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	79000000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	8378000000	USD
CY2020	us-gaap	Goodwill Transfers GoodwillTransfers	-5000000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-16000000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	8357000000	USD
CY2021	us-gaap	Goodwill Transfers GoodwillTransfers	2000000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	18000000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	7989000000	USD
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	USD
CY2021Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4916000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2823000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2093000000	USD
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4928000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2823000000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2105000000	USD
CY2020Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	23000000	USD
CY2020Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	23000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5831000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2936000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2895000000	USD
CY2020Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5854000000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2936000000	USD
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2918000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	428000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	512000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	531000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	315000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	287000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	264000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	238000000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	212000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	125000000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	119000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	134000000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16000000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	13000000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	24000000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	17000000	USD
CY2021	us-gaap	Lease Cost LeaseCost	159000000	USD
CY2020	us-gaap	Lease Cost LeaseCost	164000000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	153000000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	479000000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	115000000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15000000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	138000000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	445000000	USD
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19000000	USD
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000000	USD
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	45000000	USD
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	25000000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	64000000	USD
CY2020Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	34000000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2020Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.029
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.029
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.015
CY2020Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.024
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3000000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	82000000	USD
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	53000000	USD
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	66000000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	95000000	USD
CY2021	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	61000000	USD
CY2020	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	56000000	USD
CY2019	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	30000000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	114000000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	122000000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	125000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	150000000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	45000000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	40000000	USD
CY2019Q3	cah	Reclassificationofdeferredrentinaccordancewith Asc842 ReclassificationofdeferredrentinaccordancewithASC842	22000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due Year One LesseeLeaseLiabilityPaymentsDueYearOne	136000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due Year Two LesseeLeaseLiabilityPaymentsDueYearTwo	113000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due Year Three LesseeLeaseLiabilityPaymentsDueYearThree	86000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due Year Four LesseeLeaseLiabilityPaymentsDueYearFour	73000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due Year Five LesseeLeaseLiabilityPaymentsDueYearFive	53000000	USD
CY2021Q2	cah	Lessee Lease Liability Payments Due After Year Five LesseeLeaseLiabilityPaymentsDueAfterYearFive	146000000	USD
CY2021Q2	cah	Total Lease Liability Payments Due TotalLeaseLiabilityPaymentsDue	607000000	USD
CY2021Q2	cah	Total Lease Liability Not Yet Commenced Amount TotalLeaseLiabilityNotYetCommencedAmount	3000000	USD
CY2021Q2	cah	Total Lease Liability Undiscounted Excess Amount TotalLeaseLiabilityUndiscountedExcessAmount	61000000	USD
CY2021Q2	cah	Total Lease Liability TotalLeaseLiability	543000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3000000000.0	USD
CY2021Q2	us-gaap	Other Borrowings OtherBorrowings	67000000	USD
CY2020Q2	us-gaap	Other Borrowings OtherBorrowings	35000000	USD
CY2021Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6236000000	USD
CY2020Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6775000000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	871000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	10000000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5365000000	USD
CY2020Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6765000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	872000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	584000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	808000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	418000000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	525000000	USD
CY2021Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	23700000000	USD
CY2020Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	21400000000	USD
CY2019	cah	Notes Payable Repurchased NotesPayableRepurchased	100000000	USD
CY2021	cah	Offer As Percentage Of Principal Amount OfferAsPercentageOfPrincipalAmount	1.01
CY2021Q2	us-gaap	Other Borrowings OtherBorrowings	67000000	USD
CY2020Q2	us-gaap	Other Borrowings OtherBorrowings	35000000	USD
CY2021	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	112000000	USD
CY2020	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	16000000	USD
CY2019	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	94000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-47000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4056000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1478000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	370000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	284000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	273000000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-785000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	323000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3772000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1751000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-989000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	659000000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	295000000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	92000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	154000000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	89000000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	112000000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	69000000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	85000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	882000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	469000000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	539000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-822000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-28000000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-28000000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-127000000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-37000000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-15000000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-12000000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-18000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	496000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-961000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-83000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-289000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-79000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	386000000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.032
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.025
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2021	cah	Effective Income Tax Rate Reconciliation Tax Effect Of Foreign Operations EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations	0.007
CY2020	cah	Effective Income Tax Rate Reconciliation Tax Effect Of Foreign Operations EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations	0
CY2019	cah	Effective Income Tax Rate Reconciliation Tax Effect Of Foreign Operations EffectiveIncomeTaxRateReconciliationTaxEffectOfForeignOperations	-0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.016
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.002
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.070
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	cah	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	0.090
CY2020	cah	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	-0.003
CY2019	cah	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.014
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.015
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.045
CY2021	cah	Effective Tax Rate Reconciliation Us Taxes On International Income EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome	-0.067
CY2020	cah	Effective Tax Rate Reconciliation Us Taxes On International Income EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome	0.002
CY2019	cah	Effective Tax Rate Reconciliation Us Taxes On International Income EffectiveTaxRateReconciliationUSTaxesOnInternationalIncome	0.007
CY2021	cah	Effective Tax Rate Reconciliation Impact Of Resolutions With Irs And Other Related Matters EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters	-0.136
CY2020	cah	Effective Tax Rate Reconciliation Impact Of Resolutions With Irs And Other Related Matters EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters	-0.004
CY2019	cah	Effective Tax Rate Reconciliation Impact Of Resolutions With Irs And Other Related Matters EffectiveTaxRateReconciliationImpactOfResolutionsWithIRSAndOtherRelatedMatters	-0.001
CY2021	cah	Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent	0
CY2020	cah	Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent	0
CY2019	cah	Effective Income Tax Rate Reconciliation Legal Entity Reorganization Reconciling Items Percent EffectiveIncomeTaxRateReconciliationLegalEntityReorganizationReconcilingItemsPercent	-0.036
CY2021	cah	Effective Income Tax Reconciliation Opioid Litigation EffectiveIncomeTaxReconciliationOpioidLitigation	0.177
CY2020	cah	Effective Income Tax Reconciliation Opioid Litigation EffectiveIncomeTaxReconciliationOpioidLitigation	-0.232
CY2019	cah	Effective Income Tax Reconciliation Opioid Litigation EffectiveIncomeTaxReconciliationOpioidLitigation	0
CY2021	cah	Effective Income Tax Rate Reconciliation Loss Carryback Claims EffectiveIncomeTaxRateReconciliationLossCarrybackClaims	-1.299
CY2020	cah	Effective Income Tax Rate Reconciliation Loss Carryback Claims EffectiveIncomeTaxRateReconciliationLossCarrybackClaims	0
CY2019	cah	Effective Income Tax Rate Reconciliation Loss Carryback Claims EffectiveIncomeTaxRateReconciliationLossCarrybackClaims	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.006
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.021
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.897
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.021
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.897
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.021
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221
CY2021	cah	Effective Tax Rate Impact From Certain Foreign Jurisdictions EffectiveTaxRateImpactFromCertainForeignJurisdictions	20000000	USD
CY2021	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Income Tax Expense TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsIncomeTaxExpense	825000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	40000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	39000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	874000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	607000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	38000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	38000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	805000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	589000000	USD
CY2021Q2	cah	Deferred Tax Assets Relatedtouncertaintaxpositions DeferredTaxAssetsRelatedtouncertaintaxpositions	35000000	USD
CY2020Q2	cah	Deferred Tax Assets Relatedtouncertaintaxpositions DeferredTaxAssetsRelatedtouncertaintaxpositions	52000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	16000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	87000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1808000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1412000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	515000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	470000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1293000000	USD
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	942000000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1119000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1083000000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	375000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	327000000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	733000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	751000000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	975000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	0	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	23000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3225000000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2161000000	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1932000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1219000000	USD
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	52000000	USD
CY2020Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	39000000	USD
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	1981000000	USD
CY2020Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	1258000000	USD
CY2021Q2	cah	Deferred Income Taxes And Other Tax Liabilities Transferred To Held For Sale Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent	3000000	USD
CY2020Q2	cah	Deferred Income Taxes And Other Tax Liabilities Transferred To Held For Sale Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesTransferredToHeldForSaleNoncurrent	0	USD
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1932000000	USD
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1219000000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	805000000	USD
CY2021Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	477000000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	932000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	998000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	456000000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	849000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	753000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	303000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	998000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	456000000	USD
CY2018Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	423000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	121000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	500000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	24000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	223000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	78000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	39000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	138000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	27000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	5000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	271000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	6000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	25000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	932000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	998000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	456000000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	49000000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	146000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	122000000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	16000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	8000000	USD
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	96000000	USD
CY2021Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	46000000	USD
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	74000000	USD
CY2021Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4000000	USD
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	21000000	USD
CY2021	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	0	USD
CY2020	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	0	USD
CY2021Q2	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	6236000000	USD
CY2020Q2	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	6775000000	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	612000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3693000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1365000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	611000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3696000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1363000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	292000000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	293000000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	300000000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	294000000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	293000000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	301000000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.09
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.61
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.55
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.61
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.53
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7000000	shares
CY2021	cah	Sharesthatwouldbeantidilutiveasaresultofnetloss Sharesthatwouldbeantidilutiveasaresultofnetloss	2000000	shares
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021	us-gaap	Revenues Revenues	162467000000	USD
CY2020	us-gaap	Revenues Revenues	152922000000	USD
CY2019	us-gaap	Revenues Revenues	145534000000	USD
CY2021	us-gaap	Revenues Revenues	162467000000	USD
CY2020	us-gaap	Revenues Revenues	152922000000	USD
CY2019	us-gaap	Revenues Revenues	145534000000	USD
CY2021	us-gaap	Revenues Revenues	162467000000	USD
CY2020	us-gaap	Revenues Revenues	152922000000	USD
CY2019	us-gaap	Revenues Revenues	145534000000	USD
CY2019	cah	Pre Tax Gainon Divestiture PreTaxGainonDivestiture	508000000	USD
CY2021	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	27000000	USD
CY2020	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	69000000	USD
CY2019	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	55000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	472000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4098000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	2060000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	783000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	913000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	400000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	375000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328000000	USD
CY2021Q2	us-gaap	Assets Assets	44453000000	USD
CY2020Q2	us-gaap	Assets Assets	40766000000	USD
CY2019Q2	us-gaap	Assets Assets	40963000000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2360000000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2366000000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2356000000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	89000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	90000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16000000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.78
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	42.36
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5000000	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	65.15
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	43.08
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4000000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.46
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4000000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	68.62
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	55000000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	66000000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	99000000	USD
CY2020Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	729000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2702000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2488000000	USD
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	944000000	USD
CY2019Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	687000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2407000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2366000000	USD
CY2020Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	729000000	USD
CY2018Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	626000000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2353000000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1000000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2293000000	USD
CY2019Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	687000000	USD

Files In Submission

Name	View Source	Status
0000721371-21-000080-index-headers.html	Edgar Link	pending
0000721371-21-000080-index.html	Edgar Link	pending
0000721371-21-000080.txt	Edgar Link	pending
0000721371-21-000080-xbrl.zip	Edgar Link	pending
a21q4_10kx063021xexhibit311.htm	Edgar Link	pending
a21q4_10kx063021xexhibit312.htm	Edgar Link	pending
a21q4_10kx063021xexhibit321.htm	Edgar Link	pending
a21q4_10kx063021xexhibit991.htm	Edgar Link	pending
a21q4_10kx63021xexhibit211.htm	Edgar Link	pending
a21q4_10kx63021xexhibit231.htm	Edgar Link	pending
cah-20210630.htm	Edgar Link	pending
cah-20210630.xsd	Edgar Link	pending
cah-20210630_cal.xml	Edgar Link	unprocessable
cah-20210630_def.xml	Edgar Link	unprocessable
cah-20210630_g1.jpg	Edgar Link	pending
cah-20210630_g2.jpg	Edgar Link	pending
cah-20210630_g3.jpg	Edgar Link	pending
cah-20210630_g4.jpg	Edgar Link	pending
cah-20210630_g5.jpg	Edgar Link	pending
cah-20210630_g6.jpg	Edgar Link	pending
cah-20210630_g7.jpg	Edgar Link	pending
cah-20210630_htm.xml	Edgar Link	completed
cah-20210630_lab.xml	Edgar Link	unprocessable
cah-20210630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2020 Q2 Form 10-K Financial Statement

#000072137121000080 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2020 Q2 Form 10-K Financial Statement

#000072137121000080 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah